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Abstract: An artificial heme enzyme was created through self-
assembly from hemin and the lactococcal multidrug resistance
regulator (LmrR). The crystal structure shows the heme bound
inside the hydrophobic pore of the protein, where it appears
inaccessible for substrates. However, good catalytic activity and
moderate enantioselectivity was observed in an abiological
cyclopropanation reaction. We propose that the dynamic
nature of the structure of the LmrR protein is key to the
observed activity. This was supported by molecular dynamics
simulations, which showed transient formation of opened
conformations that allow the binding of substrates and the
formation of pre-catalytic structures.
Engineered heme proteins such as cytochrome P450
enzymes, myoglobin, and cyctochrome C have emerged as
excellent catalysts for new-to-nature reactions,[1, 2] including
carbene-transfer reactions such as cyclopropanations,[3–7]
olefinations, and[8, 9] N@H,[10,11] Si@H,[12] and B@H insertion
reactions.[13] These enzymes have proven amenable to opti-
mization by both genetic methods and co-factor replace-
ment.[14–20] A common feature of these (designed) heme
enzymes is that they contain a large hydrophobic substrate
binding pocket orthogonal to the plane of the heme moiety.
Alternatively, significant effort has been devoted to the
de novo design of heme proteins, particularly based on 4-helix
bundles,[21–25] antibodies, or other proteins,[26,27] yet none of
these has found application in catalysis of new-to-nature
reactions. A key difference is that these artificial heme
enzymes generally do not present a defined binding site
suitable for binding the often hydrophobic substrates. Here,
we report a novel artificial heme enzyme based on the
lactococcal multidrug resistance regulator (LmrR), which is
capable of catalyzing abiological enantioselective cyclopro-
panation reactions. Moreover, we propose that the structural
dynamics of the artificial heme enzyme are key to its catalytic
activity.
LmrR is a homodimeric protein with a unique and highly
dynamic structure that is key to its biological function.[28,29] It
presents an unusually large hydrophobic and promiscuous
binding pocket at the dimer interface, which has proven to be
very suitable for the creation of a novel active site through
anchoring of a catalytically active CuII complex inside. The
resulting artificial metalloenzymes have been applied suc-
cessfully in enantioselective Lewis acid catalysis.[30–33] In
particular, supramolecular assembly of the artificial metal-
loenzyme through combination with a CuII-phenanthroline
complex proved powerful, giving rise to excellent enantiose-
lectivity in the Friedel–Crafts alkylation reaction.[34] The
diversity of reactions catalyzed by LmrR-based artificial
enzymes led us to believe that the LmrR scaffold could be
extended to other catalyst types, including heme-based
catalysts.
The design was based on an LmrR variant that includes
a C-terminal strep-tag and has two mutations in the DNA
binding domain (K55D and K59Q), which facilitates expres-
sion and purification.[31] A second mutant, LmrR_W96A, was
prepared to assess the effect of the tryptophan residues in the
hydrophobic pore (W96 and W96’, with the prime denoting
the dimer related subunit), which are known to play a role in
the binding of guest molecules.[28]
The artificial heme enzymes were created through self-
assembly by adding iron (III) chloroprotoporphyrin IX
(Hemin) to the corresponding protein LmrR variant in
a buffered solution (50 mm KHPO4, 150 mm NaCl, pH 7;
Scheme 1). The interaction of hemin with LmrR was exam-
ined by electronic absorption spectroscopy. The visible
spectrum of hemin at pH 7.0 (Figure 1a) exhibits a broad
Soret band and a weak peak around 610 nm in the Q band
region, which is characteristic of a p–p porphyrin dimer that
was previously shown to predominate in aqueous hemin
solutions at neutral pH.[35,36] Addition of LmrR caused
a substantial sharpening in the Soret and Q-band regions,
resulting in a spectrum that is similar to that of hemin in
organic solvents.[36] Clearly, upon addition of the protein, the
dimeric porphyrin structure is disrupted and the hemin is in
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a monomeric form. Monitoring spectral changes as a function
of added protein indicates that hemin binds to LmrR with
a ratio of one hemin per dimeric protein. This stoichiometry
was further confirmed by monitoring tryptophan fluorescence
quenching, which was complete upon the addition of 1 equiv-
alent of hemin per LmrR dimer (Figure 1b). Fitting of
fluorescence titration data yields a dissociation constant (KD)
of 38: 27 nm, thus indicating that the affinity of the protein
for hemin is quite high, and is in fact comparable to or
stronger than previously measured for other flat, planar
molecules.[28]
In contrast, UV/vis titration of hemin with LmrR_W96A
results in a loss of spectral intensity, but no substantial change
in spectral line shape, likely owing to non-specific binding on
the protein surface (Figure S4). These results clearly show
thatW96/W96’ play a key role in the interaction of hemin with
LmrR, leading to a monomeric hemin structure, and indicate
that hemin lies either partly or entirely within the hydro-
phobic pocket.
The Hemin/LmrR stoichiometry and the importance of
W96/W96’ in complex formation are further supported by the
crystal structure of LmrR co-crystallized with hemin (Figure 2
and Figure S6). Crystals diffracting to sufficiently high
resolution could be obtained only for an LmrR that had the
K55 and K59 residues reintroduced. The overall conforma-
tion of LmrR is similar to that observed in previously
published drug-bound complexes.[28] Electron density in
between the indole rings of the central W96/W96’ pair is
attributed to the presence of the bound heme. Clear density is
observed only for the porphyrin ring, owing in part to
a crystallographic 2-fold axis, but also to a lack of specific
stabilizing interactions with the polar peripheral heme sub-
stituents. The heme, lacking the axial chloride ligand, was
modelled in the LmrR crystal structure with four alternate
binding modes, differing by rotations around a central axis
perpendicular to the plane of the heme, and by a flip of the
heme due the crystallographic 2-fold symmetry (Figure S6).
In all binding modes, the heme iron is shielded at either side
of the heme by the indole ring of W96 and W96’ and lies at an
average distance of around 4 c from the carbon atoms, thus
suggesting cation–p interactions. Further stabilization is
provided by van der Waals contacts with hydrophobic
residues in the vicinity of the central tryptophan pair,
namely, M8, A11, and V15 (and their equivalents from the
dimer mate). This structure is unlikely to allow catalysis since
the catalytic iron is fully shielded and cannot be accessed by
substrates. However, the crystal structure already suggests
considerable dynamics in the binding of the heme, which may
include catalytically viable conformations. This was supported
by molecular dynamics (MD) simulations (see below).
The potential of the artificial heme enzymes in catalysis
was examined in the cyclopropanation of o-methoxystyrene
(1a) with ethyldiazoacetate (EDA, 2) under anaerobic
conditions as the benchmark reaction (Table 1 and
Table S4). In the absence of LmrR, the reaction was sluggish,
and diethyl fumarate (4), which results from the dimerization
of EDA, was found as the major product (entry 1). The
artificial heme enzyme (LmrR%heme) was assembled in situ
by adding 1 mol% of hemin to a slight excess (1.1 equiv) of
LmrR in previously deoxygenated 50 mm KPi buffer pH 8.0.
The LmrR%heme-catalyzed reaction requires addition of
Scheme 1. Schematic representation of the assembly of the LmrR-
based artificial heme enzyme and the catalyzed enantioselective cyclo-
propanation reaction.
Figure 1. a) Electronic absorption spectra upon the addition of LmrR
to 5 mm hemin. Inset: Changes in absorption values as a function of
protein concentration. Buffer: 50 mm phosphate buffer/150 mm NaCl,
pH 7.0. b) Fluorescence spectra upon the addition of hemin to 1 mm
LmrR dimer. Inset: Fraction of LmrR bound to hemin as a function of
added hemin concentration. Buffer: 50 mm phosphate buffer/150 mm
NaCl, pH 7.0.
Figure 2. Crystal structure of LmrR%heme (PDB ID: 6FUU). The pro-
tein crystallized in a tetragonal crystal form with one polypeptide chain
occupying the asymmetric unit; the functional dimer (here shown in
cartoon representation) is formed by a crystallographic dyad. In the
electron density maps, the polypeptide chain is well defined, except for
the tip region of the b-wing (residues 70–73) and the N- and C-termini
(residues 1–4 and 109–131, including the C-terminal strep-tag). These
regions show a high degree of disorder and were excluded from the
final model. The heme is stacked in between the side chains of W96/
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sodium dithionate as a reductant to generate the FeII heme,
which is the active complex required for carbene generation.
The reaction was started by adding 30 mm of 1a and 10 mm of
2. After 18 h at 4 8C, the trans isomer of the cyclopropanation
product 3a (trans/cis= 92:8) was obtained as the major
product in 25% yield, which corresponds to a total turnover
number (TTN) of 247, and with an ee of 17%. (entry 2). The
only detectable side product was diethyl fumarate (4), with 28
turnovers. These results clearly show the acceleration and
chemoselectivity due to the LmrR scaffold compared to the
reactions catalyzed by hemin alone under the same condi-
tions.
The role of the protein scaffold was explored further by
mutagenesis of residues in and around the hydrophobic pore.
In addition to W96 (see above), residues M8, V15, F93, and
D100 were mutated to alanine (see the Supporting Informa-
tion). With the exception of V15A, all mutants showed
significant protein enhanced catalytic activity that was com-
parable or greater than LmrR itself (entry 3–7). Surprisingly,
this was also the case for LmrR_W96A, albeit with a complete
loss of enantioselectivity. We attribute this to hemin–
LmrR_W96A association away from the hydrophobic pore,
which may result in assemblies that are catalytically active but
lack the defined chiral interactions to induce enantioselec-
tivity. A significant increase in activity was observed in case of
the mutants D100A and M8A, with the latter also giving rise
to the highest enantioselectivity of 44% ee (entry 7).
Further optimization of the reactions conditions was
performed with this mutant (Tables S5,6). It was found that
a threefold excess of styrene over EDA and pH 7.0 gave the
optimal conditions in terms of activity and selectivity
(entry 8).
The activity of LmrR_M8A%heme was compared for
substrates 1a–c. (entries 8–12). In all cases, the artificial heme
enzyme significantly outperformed the free hemin cofactor.
The enantioselectivity observed ranged from 25% ee in the
case of 3c (entry 12) to 51% ee in the case of 3a (entry 8).
The observed catalytic activity and enantioselectivity are
difficult to rationalize based on the crystal structure, which
shows the catalytic iron center sandwiched between the two
tryptophan residues, where it is inaccessible for the substrates.
To gain more insight into the origin of the catalytic activity,
computational studies were performed.
Calculations were focused on determining the conforma-
tional rearrangement required for LmrR%heme to allow
substrate binding and the reaction to take place. Local and
global rearrangements of the protein were assessed for the
binding of the heme as well as in presence of the substrates by
combining protein–ligand docking, quantum mechanics cal-
culations, and large-scale molecular dynamics simulations.
Protein–ligand dockings of both the heme (5) and its
adduct with the carbene intermediate (6 ; Figure S6) were
carried out on LmrR, starting from the LmrR%heme crystal
structure. Local rearrangements were assessed by introducing
rotameric flexibility for all the amino acids at the dimer
interface. For 5 and 6, four binding poses with good predicted
affinity (ChemScore values higher than 50 units) were found
for both cases (Table S3). They correspond to different
orientations of the heme group as a result of rotations
around the axis perpendicular to the average plane of the
heme passing through the metal. The best docking solutions
of LmrR%5 show the heme sandwiched between W96/W96’,
similar to the crystal structure. However, in the case of the
carbene complex (LmrR%6), some low-energy solutions
present W96’ rotated towards the solvent, thus providing
space to accommodate the co-substrate (Figure S1 in the
Supporting Information). To assess the structural rearrange-
ment of LmrR upon heme binding, the four predicted
structures of LmrR%5 and LmrR%6 were submitted to
100 ns MD simulations.
Cluster analysis shows high stability for the LmrR%heme
complex (Figure S8), with W96 and W96’ generating a hydro-
phobic patch that sandwiches the heme. Some of the most
populated clusters of the LmrR%5 system (clusters 1 and 3–6)
show high similarity with the crystal structure, with the iron
atom inaccessible to solvent (Figure 3a). On the other hand,
clusters 0 and 2 (see the Supporting Information for details)
show changes in the orientation of the a helix containingW96’
(a4) and a flip of the W96’ indole towards the outside of the
pore (Figure 3b and Figure S10). These predicted conforma-
tional changes are in agreement with previous reports in
which it was suggested that flexibility in the orientation of a4
is a major contributor to the ability of LmrR to structurally
adapt to different drug molecules.[29] These changes in the
protein structure are accompanied by a significant displace-
ment of the heme towards the solvent. The result is an opened
conformation that has significant free space on the axial face
of the heme group. This appears to be of key importance to
catalysis, since the iron site becomes accessible to bind the
carbene, which allows the reaction occur.
MD simulations of the LmrR%heme–carbene complex
(LmrR%6) show that this opened conformation is indeed
capable of accommodating the carbene moiety. The simula-
tions further underline the importance of W96’ in controlling
the accessibility of the heme–carbene complex. With W96’
pointing towards the hydrophobic core, the heme–carbene is
directed towards the solvent, where it will be accessible for
the styrene co-substrate (Figure 3c). Rotation of W96’ to the
Table 1: Results of cyclopropanation reaction of styrene derivatives 1a–c
with EDA (2) catalyzed by LmrR%heme.[a]
entry LmrR 1[c] 3 Yield [%] TTN 3/4 ee [%][b]
1 – 1a 3a 5:2 51 0.8 –
2 LmrR 1a 3a 25:11 247 11 17:5
3 LmrR_F93A 1a 3a 23:2 232 9 11:1
4 LmrR_D100A 1a 3a 38:8 375 20 24:5
5 LmrR_W96A 1a 3a 28:13 276 8 <5
6 LmrR_V15A 1a 3a 1.5:0.5 15 3 17:1
7 LmrR_M8A 1a 3a 36:13 359 15 44:12
8[c] LmrR_M8A 1a 3a 45:9 449 6 51:14
9[c] – 1b 3b 6:0 59 n.d –
10[c] LmrR_M8A 1b 3b 39:13 391 n.d 38:5{d}
11[c] – 1c 3c 1:0 12 0.2 –
12[c] LmrR_M8A 1c 3c 35:13 351 3 25:5
[a] Conditions: 1 (30 mm), 2 (10 mm), hemin (1 mol%; 10 mm), LmrR_X
(1.1 mol%; 11 mm) in 50 mm phosphate buffer (pH 8.0), under Ar, at 4 8C
for 18 h; Results are the average of at least two independent experi-
ments, both carried out in duplicate. [b] ee of the trans product; trans/
cis>85:15. [c] pH 7.0. [d] ee of the 1R, 2R enantiomer.[37]
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outside of the pore causes the heme–carbene (6) to remain at
the dimer interface (Figure 3d, S8).
Finally, the effect of the second substrate (styrene) was
studied. First, the transition-state (TS) geometry that leads to
the generation of the 1R,2R cyclopropane was obtained by
QM calculations (Figure S7) and then subjected to the same
analysis as before (Table S3). The majority of the structures
(clusters 0, 2 and 3) correspond to LmrR with a broader dimer
interface where the two helices containing the W96/W96’
residues appear further separated and are thus capable of
accommodating the catalytic complex (Figure 3e). W96’
appears to be involved in stabilizing the TS structure through
p stacking with the phenyl group of the styrene.
Since theM8Amutant showed the best results in catalysis,
the dynamic behavior of this artificial metalloenzyme was also
studied. For consistency, all the simulations were carried out
under the same conditions as before. The system resulting
from the docking of the heme linked to the TS structure for
the 1R,2R enantiomeric product into the LmrR protein was
selected as a starting point for a 100 ns MD simulation, which
suggests that the effect of this mutation is mainly steric: the
aromatic moiety of the styrene now occupies the free space
resulting from the change of the large methionine into the
much smaller alanine. Additionally, W96’ is flipped towards
the solvent and thus contributes to binding of the TS structure
into the dimer interface (Figure 3 f).
The combined results demonstrate unequivocally that the
cyclopropanation reaction occurs in the hydrophobic pocket
of LmrR. Initially, this is counterintuitive: heme enzymes
such as P450 enzymes usually present a large hydrophobic
cavity for binding substrates whereas, in contrast, upon
binding of hemin, the pocket of LmrR is fully occupied.
However, the artificial enzyme exhibits good activity and
shows enantioselectivity in catalysis. This is attributed to the
dynamic nature of the LmrR-based artificial heme enzyme,
involving substantial geometric rearrangement of the heme
environment to allow binding of the substrates and their
interaction with the heme. Indeed, the MD simulations show
that the LmrR%heme complex undergoes significant con-
formational changes, giving rise to transient open conforma-
tions that make it possible to reach a pre-catalytic state,
thereby allowing the reaction to proceed.
In conclusion, we have created an artificial heme enzyme
based on the protein LmrR, which shows good activity and
moderate enantioselectivity in an abiological reaction, that is,
the catalytic cyclopropanation of styrenes. This is the first
example of organometallic catalysis with an LmrR-based
artificial metalloenzyme and thus illustrates the versatility of
LmrR as a scaffold for artificial metalloenzymes design. A
key finding is that the enzyme is active despite the fact that
the crystal structure shows a tightly bound heme that appears
inaccessible to substrates. It is proposed that the artificial
enzyme can open up to allow formation of precatalytic
structures as a result of a dynamic protein–heme assembly.
Molecular dynamics studies add support to this hypothesis.
This work suggests that dynamics have to be taken into
account in the design of artificial enzymes and may be key to
achieving catalytic activity.
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